Is Arvinas Stock a Good Investment?
Arvinas Investment Advice | ARVN |
- Examine Arvinas' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Arvinas' leadership team and their track record. Good management can help Arvinas navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Arvinas' business and its evolving consumer preferences.
- Compare Arvinas' performance and market position to its competitors. Analyze how Arvinas is positioned in terms of product offerings, innovation, and market share.
- Check if Arvinas pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Arvinas' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Arvinas stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Arvinas is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Arvinas Stock
Researching Arvinas' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 93.0% of the company shares are held by institutions such as insurance companies. The book value of Arvinas was presently reported as 8.53. The company has Price/Earnings To Growth (PEG) ratio of 0.28. Arvinas recorded a loss per share of 4.79. The entity had not issued any dividends in recent years.
To determine if Arvinas is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Arvinas' research are outlined below:
| Arvinas had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 78.5 M. Net Loss for the year was (367.3 M) with profit before overhead, payroll, taxes, and interest of 131.4 M. | |
| Arvinas currently holds about 1.27 B in cash with (347.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 23.87. | |
| Arvinas has a poor financial position based on the latest SEC disclosures | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast ... |
Arvinas uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Arvinas. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Arvinas' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 3rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Arvinas' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Arvinas' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-08-04 | 2020-06-30 | -0.59 | -0.65 | -0.06 | 10 | ||
2019-03-26 | 2018-12-31 | -0.61 | -0.52 | 0.09 | 14 | ||
2020-11-05 | 2020-09-30 | -0.68 | -0.79 | -0.11 | 16 | ||
2019-08-05 | 2019-06-30 | -0.4 | -0.55 | -0.15 | 37 | ||
2021-08-05 | 2021-06-30 | -0.86 | -1.03 | -0.17 | 19 | ||
2022-02-28 | 2021-12-31 | -0.79 | -1.0 | -0.21 | 26 | ||
2021-03-01 | 2020-12-31 | -0.78 | -0.99 | -0.21 | 26 | ||
2024-10-30 | 2024-09-30 | -0.96 | -0.68 | 0.28 | 29 |
Arvinas Target Price Consensus
Arvinas target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Arvinas' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 21 | Strong Buy |
Most Arvinas analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Arvinas stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Arvinas, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationArvinas Target Price Projection
Arvinas' current and average target prices are 26.72 and 65.00, respectively. The current price of Arvinas is the price at which Arvinas is currently trading. On the other hand, Arvinas' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Arvinas Target Price
Arvinas Analyst Ratings
Arvinas' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Arvinas stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Arvinas' financials, market performance, and future outlook by experienced professionals. Arvinas' historical ratings below, therefore, can serve as a valuable tool for investors.Know Arvinas' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Arvinas is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arvinas backward and forwards among themselves. Arvinas' institutional investor refers to the entity that pools money to purchase Arvinas' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.6 M | Geode Capital Management, Llc | 2024-09-30 | 1.5 M | Avidity Partners Management Lp | 2024-09-30 | 1.5 M | New Leaf Venture Partners, L.l.c. | 2024-09-30 | 1.4 M | Nextech Invest Ag | 2024-09-30 | 1.4 M | Braidwell Lp | 2024-09-30 | 1.3 M | Opaleye Management Inc | 2024-09-30 | 1.3 M | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 1.2 M | Commodore Capital Lp | 2024-09-30 | 1.2 M | Vanguard Group Inc | 2024-09-30 | 7 M | Ecor1 Capital, Llc | 2024-09-30 | 6.7 M |
Arvinas' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.84 B.Market Cap |
|
Arvinas' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.30) | |
| Return On Capital Employed | (0.38) | (0.40) | |
| Return On Assets | (0.28) | (0.30) | |
| Return On Equity | (0.56) | (0.58) |
Determining Arvinas' profitability involves analyzing its financial statements and using various financial metrics to determine if Arvinas is a good buy. For example, gross profit margin measures Arvinas' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Arvinas' profitability and make more informed investment decisions.
Evaluate Arvinas' management efficiency
Arvinas has return on total asset (ROA) of (0.2007) % which means that it has lost $0.2007 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5916) %, meaning that it created substantial loss on money invested by shareholders. Arvinas' management efficiency ratios could be used to measure how well Arvinas manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to drop to -0.3. In addition to that, Return On Capital Employed is likely to drop to -0.4. At this time, Arvinas' Non Currrent Assets Other are very stable compared to the past year. As of the 30th of November 2024, Fixed Asset Turnover is likely to grow to 5.73, while Total Assets are likely to drop about 753.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 11.89 | 7.71 | |
| Tangible Book Value Per Share | 11.89 | 7.71 | |
| Enterprise Value Over EBITDA | (5.00) | (5.25) | |
| Price Book Value Ratio | 3.46 | 3.29 | |
| Enterprise Value Multiple | (5.00) | (5.25) | |
| Price Fair Value | 3.46 | 3.29 | |
| Enterprise Value | 2.5 B | 2.6 B |
The leadership approach at Arvinas' fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 1.967 |
Basic technical analysis of Arvinas Stock
As of the 30th of November, Arvinas shows the Downside Deviation of 3.63, mean deviation of 2.59, and Risk Adjusted Performance of 0.0329. Arvinas technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Arvinas' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arvinas insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arvinas' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Arvinas insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Arvinas' Outstanding Corporate Bonds
Arvinas issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Arvinas uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Arvinas bonds can be classified according to their maturity, which is the date when Arvinas has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Arvinas' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Arvinas' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0329 | |||
| Market Risk Adjusted Performance | 0.0596 | |||
| Mean Deviation | 2.59 | |||
| Semi Deviation | 3.49 | |||
| Downside Deviation | 3.63 | |||
| Coefficient Of Variation | 3040.02 | |||
| Standard Deviation | 3.42 | |||
| Variance | 11.71 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.47) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0496 | |||
| Maximum Drawdown | 17.13 | |||
| Value At Risk | (5.50) | |||
| Potential Upside | 4.85 | |||
| Downside Variance | 13.16 | |||
| Semi Variance | 12.17 | |||
| Expected Short fall | (2.48) | |||
| Skewness | 0.0124 | |||
| Kurtosis | 1.2 |
| Risk Adjusted Performance | 0.0329 | |||
| Market Risk Adjusted Performance | 0.0596 | |||
| Mean Deviation | 2.59 | |||
| Semi Deviation | 3.49 | |||
| Downside Deviation | 3.63 | |||
| Coefficient Of Variation | 3040.02 | |||
| Standard Deviation | 3.42 | |||
| Variance | 11.71 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.47) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0496 | |||
| Maximum Drawdown | 17.13 | |||
| Value At Risk | (5.50) | |||
| Potential Upside | 4.85 | |||
| Downside Variance | 13.16 | |||
| Semi Variance | 12.17 | |||
| Expected Short fall | (2.48) | |||
| Skewness | 0.0124 | |||
| Kurtosis | 1.2 |
Consider Arvinas' intraday indicators
Arvinas intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Arvinas stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Arvinas Corporate Filings
8K | 19th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 27th of June 2024 Other Reports | ViewVerify | |
F3 | 26th of June 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Arvinas Stock media impact
Far too much social signal, news, headlines, and media speculation about Arvinas that are available to investors today. That information is available publicly through Arvinas media outlets and privately through word of mouth or via Arvinas internal channels. However, regardless of the origin, that massive amount of Arvinas data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arvinas news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arvinas relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arvinas' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arvinas alpha.
Arvinas Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Arvinas can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Arvinas Corporate Management
| CPA CPA | CFO Treasurer | Profile | |
| Ian Taylor | Chief Scientific Officer | Profile | |
| Paul McInulty | Senior Affairs | Profile | |
| Matthew JD | Gen Sec | Profile | |
| John Grosso | Senior Operations | Profile | |
| Randy Teel | Senior Development | Profile |
Already Invested in Arvinas?
The danger of trading Arvinas is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arvinas is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arvinas. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arvinas is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.79) | Revenue Per Share 2.327 | Quarterly Revenue Growth 1.96 | Return On Assets (0.20) | Return On Equity (0.59) |
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Arvinas' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.